Skip to main content
. Author manuscript; available in PMC: 2016 Sep 1.
Published in final edited form as: Gynecol Oncol. 2015 Jun 24;138(3):656–662. doi: 10.1016/j.ygyno.2015.06.033

Figure 4. Carboplatin/gemcitabine +/- mifepristone treatment of mice bearing HeyA8 tumor xenografts.

Figure 4

Combined data from two independent in vivo experiments. Total tumor burden is indicated at days 38-39 after initial treatment, P=0.0004 between gem/carbo (0.36g, range 0.27g-0.58g) and mif/gem/carbo (0.17g, range 0.10g-0.26g) groups. Error bars represent ± SEM of tumor weights in grams, g.